|
|
Cat. No |
Model |
Description |
Unit |
Price (VATº°µµ) |
³³±â |
Àç°í |
DataSheet |
ÁÖ¹®/°ßÀû |
LCA-24-368502 |
AP16718PU-N |
Activin receptor type 1 (ACRV1)//Human, Mouse, Rat, Canine/Goat |
1/EA |
|
|
|
|
¹®ÀÇ |
|
|
|
|
|
|
Subject
|
Activin receptor type 1 (ACRV1) |
Description
|
/ Human, Mouse, Rat, Canine/Goat |
Clonality
|
Mono |
Company
|
Acris Antibodies GmbH |
Application
|
Western blot / Immunoblot |
Conjugation
|
|
Immunogen
|
|
Contents
|
Description: Manufacturer | Acris Antibodies GmbH | Quantity | 0.1 mg | Reactivity | Human, Mouse, Rat, Canine | Presentation | Aff - Purified | Applications | Western blot / Immunoblot | Host | Goat | PDF datasheet | view | Shipping to | Worldwide | Synonyms | Activin receptor type IA, ACVRLK2, ALK2, SKR1, ACRV1A | Swiss Prot Num | Q04771 | Immunogen | Peptide with sequence C-RKFKRRNQERLNPRD, from the internal region of the protein sequence | Product Type | Antibodies | Storage | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch. | References | Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006 May;38(5):525-7. Epub 2006 Apr 23. Erratum in: Nat Genet. 2007 Feb;39(2):276. FOP International Research Consortium | |
Format | State: Liquid purified Ig | ? | Purification: Affinity chromatography | ? | Buffer System: Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin | |
Specificity | This antibody reacts to ACVR1. | Application | Peptide ELISA: 1/128000. Western Blot: 0.3 - 1 µg/ml. Immunohistochemistry on paraffin sections: 4 - 6 µg/ml. | Concentration | 0,5 mg/ml | Species Reactivity | Tested: Human. | | Expected from sequence similarity:Mouse, Rat, Canine. | |
|
|
|
|